WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first rapid-acting insulin biosimilar to Novolog (insulin aspart). This new ...

If your body doesn't make enough insulin (a hormone in your body that helps regulate your blood sugar) or stops responding to it, you may need to take prescription insulin. Taking insulin regularly ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...

Dear Toni: Currently, I am on a stand-alone Part D plan with a Medicare supplement because of my serious health issues. Last week, I received information about the 2026 changes to the Medicare Part D ...

WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that the U.S. Food and Drug Administration (FDA) has accepted the ...

President Trump said Friday he will impose an additional 100% tariff on imports from China starting next month, citing new Chinese export controls — marking a significant escalation in the U.S.-China ...

Oct 10 (Reuters) - The United States of America will slap an additional 100% tariff on imports from China and impose export controls on all critical U.S.-made software from November 1, President ...

The U.S. will levy 100% tariffs against China beginning next month, President Donald Trump said Friday, announcing the duties after Beijing clamped down on export controls for rare earth materials ...

China signaled Sunday that it would not back down in the face of a 100 percent tariff threat from President Donald Trump, urging the U.S. to resolve the matter through negotiations instead of threats.

SINGAPORE, Oct 14 (Reuters) - The implementation of a U.S. tariff on Singapore's pharmaceutical exports has been delayed to allow companies to negotiate possible exemptions with the U.S.